1 Study Coverage 1.1 Acute Migraine Drugs Product Introduction 1.2 Market by Type 1.2.1 Global Acute Migraine Drugs Market Size Growth Rate by Type 1.2.2 Triptans 1.2.3 NSAIDs 1.2.4 Others 1.3 Market by Application 1.3.1 Global Acute Migraine Drugs Market Size Growth Rate by Application 1.3.2 Hospital Pharmacies 1.3.3 Drug Stores 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Acute Migraine Drugs Market Size, Estimates and Forecasts 2.1.1 Global Acute Migraine Drugs Revenue 2016-2027 2.1.2 Global Acute Migraine Drugs Sales 2016-2027 2.2 Global Acute Migraine Drugs, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Acute Migraine Drugs Historical Market Size by Region (2016-2021) 2.3.1 Global Acute Migraine Drugs Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Acute Migraine Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Acute Migraine Drugs Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Acute Migraine Drugs Sales Forecast by Region (2022-2027) 2.4.2 Global Acute Migraine Drugs Revenue Forecast by Region (2022-2027) 3 Global Acute Migraine Drugs Competitor Landscape by Players 3.1 Global Top Acute Migraine Drugs Manufacturers by Sales 3.1.1 Global Acute Migraine Drugs Sales by Manufacturer (2016-2021) 3.1.2 Global Acute Migraine Drugs Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Acute Migraine Drugs Manufacturers by Revenue 3.2.1 Key Acute Migraine Drugs Manufacturers Covered: Ranking by Revenue 3.2.2 Global Acute Migraine Drugs Revenue by Manufacturers (2016-2021) 3.2.3 Global Acute Migraine Drugs Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Acute Migraine Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Acute Migraine Drugs Revenue in 2020 3.2.6 Global Acute Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Acute Migraine Drugs Price by Manufacturers 3.4 Global Acute Migraine Drugs Manufacturing Base Distribution, Product Types 3.4.1 Acute Migraine Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Acute Migraine Drugs Product Type 3.4.3 Date of International Manufacturers Enter into Acute Migraine Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Acute Migraine Drugs Market Size by Type (2016-2021) 4.1.1 Global Acute Migraine Drugs Sales by Type (2016-2021) 4.1.2 Global Acute Migraine Drugs Revenue by Type (2016-2021) 4.1.3 Acute Migraine Drugs Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Acute Migraine Drugs Market Size Forecast by Type (2022-2027) 4.2.1 Global Acute Migraine Drugs Sales Forecast by Type (2022-2027) 4.2.2 Global Acute Migraine Drugs Revenue Forecast by Type (2022-2027) 4.2.3 Acute Migraine Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Acute Migraine Drugs Market Size by Application (2016-2021) 5.1.1 Global Acute Migraine Drugs Sales by Application (2016-2021) 5.1.2 Global Acute Migraine Drugs Revenue by Application (2016-2021) 5.1.3 Acute Migraine Drugs Price by Application (2016-2021) 5.2 Acute Migraine Drugs Market Size Forecast by Application (2022-2027) 5.2.1 Global Acute Migraine Drugs Sales Forecast by Application (2022-2027) 5.2.2 Global Acute Migraine Drugs Revenue Forecast by Application (2022-2027) 5.2.3 Global Acute Migraine Drugs Price Forecast by Application (2022-2027) 6 United States by Players, Type and Application 6.1 United States Acute Migraine Drugs Market Size YoY Growth 2016-2027 6.1.1 United States Acute Migraine Drugs Sales YoY Growth 2016-2027 6.1.2 United States Acute Migraine Drugs Revenue YoY Growth 2016-2027 6.1.3 United States Acute Migraine Drugs Market Share in Global Market 2016-2027 6.2 United States Acute Migraine Drugs Market Size by Players (International and Local Players) 6.2.1 United States Top Acute Migraine Drugs Players by Sales (2016-2021) 6.2.2 United States Top Acute Migraine Drugs Players by Revenue (2016-2021) 6.3 United States Acute Migraine Drugs Historic Market Review by Type (2016-2021) 6.3.1 United States Acute Migraine Drugs Sales Market Share by Type (2016-2021) 6.3.2 United States Acute Migraine Drugs Revenue Market Share by Type (2016-2021) 6.3.3 United States Acute Migraine Drugs Price by Type (2016-2021) 6.4 United States Acute Migraine Drugs Market Estimates and Forecasts by Type (2022-2027) 6.4.1 United States Acute Migraine Drugs Sales Forecast by Type (2022-2027) 6.4.2 United States Acute Migraine Drugs Revenue Forecast by Type (2022-2027) 6.4.3 United States Acute Migraine Drugs Price Forecast by Type (2022-2027) 6.5 United States Acute Migraine Drugs Historic Market Review by Application (2016-2021) 6.5.1 United States Acute Migraine Drugs Sales Market Share by Application (2016-2021) 6.5.2 United States Acute Migraine Drugs Revenue Market Share by Application (2016-2021) 6.5.3 United States Acute Migraine Drugs Price by Application (2016-2021) 6.6 United States Acute Migraine Drugs Market Estimates and Forecasts by Application (2022-2027) 6.6.1 United States Acute Migraine Drugs Sales Forecast by Application (2022-2027) 6.6.2 United States Acute Migraine Drugs Revenue Forecast by Application (2022-2027) 6.6.3 United States Acute Migraine Drugs Price Forecast by Application (2022-2027) 7 North America 7.1 North America Acute Migraine Drugs Market Size YoY Growth 2016-2027 7.2 North America Acute Migraine Drugs Market Facts & Figures by Country 7.2.1 North America Acute Migraine Drugs Sales by Country (2016-2021) 7.2.2 North America Acute Migraine Drugs Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Acute Migraine Drugs Market Size YoY Growth 2016-2027 8.2 Asia Pacific Acute Migraine Drugs Market Facts & Figures by Region 8.2.1 Asia Pacific Acute Migraine Drugs Sales by Region (2016-2021) 8.2.2 Asia Pacific Acute Migraine Drugs Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Acute Migraine Drugs Market Size YoY Growth 2016-2027 9.2 Europe Acute Migraine Drugs Market Facts & Figures by Country 9.2.1 Europe Acute Migraine Drugs Sales by Country (2016-2021) 9.2.2 Europe Acute Migraine Drugs Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Acute Migraine Drugs Market Size YoY Growth 2016-2027 10.2 Latin America Acute Migraine Drugs Market Facts & Figures by Country 10.2.1 Latin America Acute Migraine Drugs Sales by Country (2016-2021) 10.2.2 Latin America Acute Migraine Drugs Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Acute Migraine Drugs Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Acute Migraine Drugs Market Facts & Figures by Country 11.2.1 Middle East and Africa Acute Migraine Drugs Sales by Country (2016-2021) 11.2.2 Middle East and Africa Acute Migraine Drugs Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 GSK 12.1.1 GSK Corporation Information 12.1.2 GSK Description and Business Overview 12.1.3 GSK Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021) 12.1.4 GSK Acute Migraine Drugs Products Offered 12.1.5 GSK Recent Development 12.2 Teva 12.2.1 Teva Corporation Information 12.2.2 Teva Description and Business Overview 12.2.3 Teva Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Teva Acute Migraine Drugs Products Offered 12.2.5 Teva Recent Development 12.3 Pfizer 12.3.1 Pfizer Corporation Information 12.3.2 Pfizer Description and Business Overview 12.3.3 Pfizer Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Pfizer Acute Migraine Drugs Products Offered 12.3.5 Pfizer Recent Development 12.4 Novartis 12.4.1 Novartis Corporation Information 12.4.2 Novartis Description and Business Overview 12.4.3 Novartis Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Novartis Acute Migraine Drugs Products Offered 12.4.5 Novartis Recent Development 12.5 Sun Pharma 12.5.1 Sun Pharma Corporation Information 12.5.2 Sun Pharma Description and Business Overview 12.5.3 Sun Pharma Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Sun Pharma Acute Migraine Drugs Products Offered 12.5.5 Sun Pharma Recent Development 12.6 Grunenthal 12.6.1 Grunenthal Corporation Information 12.6.2 Grunenthal Description and Business Overview 12.6.3 Grunenthal Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Grunenthal Acute Migraine Drugs Products Offered 12.6.5 Grunenthal Recent Development 12.7 Endo Pharmaceuticals 12.7.1 Endo Pharmaceuticals Corporation Information 12.7.2 Endo Pharmaceuticals Description and Business Overview 12.7.3 Endo Pharmaceuticals Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Endo Pharmaceuticals Acute Migraine Drugs Products Offered 12.7.5 Endo Pharmaceuticals Recent Development 12.8 Merck 12.8.1 Merck Corporation Information 12.8.2 Merck Description and Business Overview 12.8.3 Merck Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Merck Acute Migraine Drugs Products Offered 12.8.5 Merck Recent Development 12.9 J & J 12.9.1 J & J Corporation Information 12.9.2 J & J Description and Business Overview 12.9.3 J & J Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021) 12.9.4 J & J Acute Migraine Drugs Products Offered 12.9.5 J & J Recent Development 12.11 GSK 12.11.1 GSK Corporation Information 12.11.2 GSK Description and Business Overview 12.11.3 GSK Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021) 12.11.4 GSK Acute Migraine Drugs Products Offered 12.11.5 GSK Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Acute Migraine Drugs Industry Trends 13.2 Acute Migraine Drugs Market Drivers 13.3 Acute Migraine Drugs Market Challenges 13.4 Acute Migraine Drugs Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Acute Migraine Drugs Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Acute Migraine Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Triptans Table 3. Major Manufacturers of NSAIDs Table 4. Major Manufacturers of Others Table 5. Global Acute Migraine Drugs Market Size Growth Rate by Application (2021-2027) & (K Unit) Table 6. Global Acute Migraine Drugs Market Size by Region (K Unit) & (US$ Million), 2016 VS 2021 VS 2027 Table 7. Global Acute Migraine Drugs Sales by Regions (2016-2021) & (K Unit) Table 8. Global Acute Migraine Drugs Sales Market Share by Regions (2016-2021) Table 9. Global Acute Migraine Drugs Revenue by Regions (2016-2021) & (US$ Million) Table 10. Global Acute Migraine Drugs Sales Forecast by Region (2022-2027) & (K Unit) Table 11. Global Acute Migraine Drugs Sales Market Share Forecast by Region (2022-2027) Table 12. Global Acute Migraine Drugs Revenue Forecast by Region (2022-2027) & (US$ Million) Table 13. Global Acute Migraine Drugs Revenue Market Share Forecast by Region (2022-2027) Table 14. Global Acute Migraine Drugs Sales by Manufacturers (2016-2021) (K Unit) Table 15. Global Acute Migraine Drugs Sales Share by Manufacturers (2016-2021) Table 16. Ranking of Global Top Acute Migraine Drugs Manufacturers by Revenue (US$ Million) in 2020 Table 17. Acute Migraine Drugs Revenue by Manufacturers (2016-2021) (US$ Million) Table 18. Acute Migraine Drugs Revenue Share by Manufacturers (2016-2021) Table 19. Global Acute Migraine Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 20. Global Acute Migraine Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Migraine Drugs as of 2020) Table 21. Key Manufacturers Acute Migraine Drugs Price (2016-2021) (USD/Unit) Table 22. Acute Migraine Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Acute Migraine Drugs Product Type Table 24. Date of International Manufacturers Enter into Acute Migraine Drugs Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global Acute Migraine Drugs Sales by Type (2016-2021) (K Unit) Table 27. Global Acute Migraine Drugs Sales Share by Type (2016-2021) Table 28. Global Acute Migraine Drugs Revenue by Type (2016-2021) (US$ Million) Table 29. Global Acute Migraine Drugs Revenue Share by Type (2016-2021) Table 30. Acute Migraine Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit) Table 31. Global Acute Migraine Drugs Sales Forecast by Type (2022-2027) & (K Unit) Table 32. Global Acute Migraine Drugs Sales Market Share Forecast by Type (2022-2027) Table 33. Global Acute Migraine Drugs Revenue Forecast V (2022-2027) & (US$ Million) Table 34. Global Acute Migraine Drugs Revenue Market Share Forecast by Type (2022-2027) Table 35. Global Acute Migraine Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit) Table 36. Global Acute Migraine Drugs Sales by Application (2016-2021) (K Unit) Table 37. Global Acute Migraine Drugs Sales Share by Application (2016-2021) Table 38. Global Acute Migraine Drugs Revenue by Application (2016-2021) (US$ Million) Table 39. Global Acute Migraine Drugs Revenue Share by Application (2016-2021) Table 40. Acute Migraine Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit) Table 41. Global Acute Migraine Drugs Sales Forecast by Application (2022-2027) & (K Unit) Table 42. Global Acute Migraine Drugs Sales Market Share Forecast by Application (2022-2027) Table 43. Global Acute Migraine Drugs Revenue Forecast by Application (2022-2027) & (US$ Million) Table 44. Global Acute Migraine Drugs Revenue Market Share Forecast by Application (2022-2027) Table 45. Global Acute Migraine Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit) Table 46. United States Acute Migraine Drugs Sales (K Unit) of Key Companies (2016-2021) Table 47. United States Acute Migraine Drugs Sales Share by Company (2016-2021) Table 48. United States Acute Migraine Drugs Revenue (US$ Million) by Company (2016-2021) Table 49. United States Acute Migraine Drugs Revenue Share by Company (2016-2021) Table 50. United States Acute Migraine Drugs Sales (K Unit) by Type (2016-2021) Table 51. United States Acute Migraine Drugs Sales Share by Type (2016-2021) Table 52. United States Acute Migraine Drugs Revenue (US$ Million) Market Share by Type (2016-2021) Table 53. United States Acute Migraine Drugs Price (USD/Unit) by Type (2016-2021) Table 54. United States Acute Migraine Drugs Sales (K Unit) by Type (2022-2027) Table 55. United States Acute Migraine Drugs Sales Share by Type (2022-2027) Table 56. United States Acute Migraine Drugs Revenue (US$ Million) Market Share by Type (2022-2027) Table 57. United States Acute Migraine Drugs Revenue Share by Type (2022-2027) Table 58. United States Acute Migraine Drugs Price (USD/Unit) by Type (2022-2027) Table 59. United States Acute Migraine Drugs Sales (K Unit) by Application (2016-2021) Table 60. United States Acute Migraine Drugs Sales Share by Application (2016-2021) Table 61. United States Acute Migraine Drugs Revenue (US$ Million) Market Share by Application (2016-2021) Table 62. United States Acute Migraine Drugs Price (USD/Unit) by Application (2016-2021) Table 63. United States Acute Migraine Drugs Sales (K Unit) by Application (2022-2027) Table 64. United States Acute Migraine Drugs Sales Share by Application (2022-2027) Table 65. United States Acute Migraine Drugs Revenue (US$ Million) Market Share by Application (2022-2027) Table 66. United States Acute Migraine Drugs Revenue Share by Application (2022-2027) Table 67. United States Acute Migraine Drugs Price (USD/Unit) by Application (2022-2027) Table 68. North America Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit) Table 69. North America Acute Migraine Drugs Sales Market Share by Country (2016-2021) Table 70. North America Acute Migraine Drugs Revenue by Country (2016-2021) & (US$ Million) Table 71. North America Acute Migraine Drugs Revenue Market Share by Country (2016-2021) Table 72. Asia Pacific Acute Migraine Drugs Sales by Region (2016-2021) & (K Unit) Table 73. Asia Pacific Acute Migraine Drugs Sales Market Share by Region (2016-2021) Table 74. Asia Pacific Acute Migraine Drugs Revenue by Region (2016-2021) & (US$ Million) Table 75. Asia Pacific Acute Migraine Drugs Revenue Market Share by Region (2016-2021) Table 76. Europe Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit) Table 77. Europe Acute Migraine Drugs Sales Market Share by Country (2016-2021) Table 78. Europe Acute Migraine Drugs Revenue by Country (2016-2021) & (US$ Million) Table 79. Europe Acute Migraine Drugs Revenue Market Share by Country (2016-2021) Table 80. Latin America Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit) Table 81. Latin America Acute Migraine Drugs Sales Market Share by Country (2016-2021) Table 82. Latin Americaa Acute Migraine Drugs Revenue by Country (2016-2021) & (US$ Million) Table 83. Latin America Acute Migraine Drugs Revenue Market Share by Country (2016-2021) Table 84. Middle East and Africa Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit) Table 85. Middle East and Africa Acute Migraine Drugs Sales Market Share by Country (2016-2021) Table 86. Middle East and Africa Acute Migraine Drugs Revenue by Country (2016-2021) & (US$ Million) Table 87. Middle East and Africa Acute Migraine Drugs Revenue Market Share by Country (2016-2021) Table 88. GSK Corporation Information Table 89. GSK Description and Business Overview Table 90. GSK Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 91. GSK Acute Migraine Drugs Product Table 92. GSK Recent Development Table 93. Teva Corporation Information Table 94. Teva Description and Business Overview Table 95. Teva Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 96. Teva Product Table 97. Teva Recent Development Table 98. Pfizer Corporation Information Table 99. Pfizer Description and Business Overview Table 100. Pfizer Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 101. Pfizer Product Table 102. Pfizer Recent Development Table 103. Novartis Corporation Information Table 104. Novartis Description and Business Overview Table 105. Novartis Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 106. Novartis Product Table 107. Novartis Recent Development Table 108. Sun Pharma Corporation Information Table 109. Sun Pharma Description and Business Overview Table 110. Sun Pharma Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 111. Sun Pharma Product Table 112. Sun Pharma Recent Development Table 113. Grunenthal Corporation Information Table 114. Grunenthal Description and Business Overview Table 115. Grunenthal Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 116. Grunenthal Product Table 117. Grunenthal Recent Development Table 118. Endo Pharmaceuticals Corporation Information Table 119. Endo Pharmaceuticals Description and Business Overview Table 120. Endo Pharmaceuticals Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 121. Endo Pharmaceuticals Product Table 122. Endo Pharmaceuticals Recent Development Table 123. Merck Corporation Information Table 124. Merck Description and Business Overview Table 125. Merck Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 126. Merck Product Table 127. Merck Recent Development Table 128. J & J Corporation Information Table 129. J & J Description and Business Overview Table 130. J & J Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 131. J & J Product Table 132. J & J Recent Development Table 133. Acute Migraine Drugs Market Trends Table 134. Acute Migraine Drugs Market Drivers Table 135. Acute Migraine Drugs Market Challenges Table 136. Acute Migraine Drugs Market Restraints Table 137. Acute Migraine Drugs Customers List Table 138. Acute Migraine Drugs Distributors List Table 139. Research Programs/Design for This Report Table 140. Key Data Information from Secondary Sources Table 141. Key Data Information from Primary Sources List of Figures Figure 1. Acute Migraine Drugs Product Picture Figure 2. Global Acute Migraine Drugs Sales Market Share by Type in 2020 & 2027 Figure 3. Triptans Product Picture Figure 4. NSAIDs Product Picture Figure 5. Others Product Picture Figure 6. Global Acute Migraine Drugs Sales Market Share by Application in 2020 & 2027 Figure 7. Hospital Pharmacies Figure 8. Drug Stores Figure 9. Acute Migraine Drugs Report Years Considered Figure 10. Global Acute Migraine Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Acute Migraine Drugs Market Size 2016-2027 (US$ Million) Figure 12. Global Acute Migraine Drugs Sales 2016-2027 (K Unit) Figure 13. Global Acute Migraine Drugs Market Size Market Share by Region: 2021 Versus 2027 Figure 14. Global Acute Migraine Drugs Sales Market Share by Region (2016-2021) Figure 15. Global Acute Migraine Drugs Sales Market Share by Region in 2020 Figure 16. Global Acute Migraine Drugs Revenue Market Share by Region (2016-2021) Figure 17. Global Acute Migraine Drugs Revenue Market Share by Region in 2020 Figure 18. Global Acute Migraine Drugs Sales Share by Manufacturer in 2020 Figure 19. The Top 10 and 5 Players Market Share by Acute Migraine Drugs Revenue in 2020 Figure 20. Acute Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 21. Global Acute Migraine Drugs Sales Market Share by Type (2016-2021) Figure 22. Global Acute Migraine Drugs Sales Market Share by Type in 2020 Figure 23. Global Acute Migraine Drugs Revenue Market Share by Type (2016-2021) Figure 24. Global Acute Migraine Drugs Revenue Market Share by Type in 2020 Figure 25. Global Acute Migraine Drugs Sales Market Share by Application (2016-2021) Figure 26. Global Acute Migraine Drugs Sales Market Share by Application in 2020 Figure 27. Global Acute Migraine Drugs Revenue Market Share by Application (2016-2021) Figure 28. Global Acute Migraine Drugs Revenue Market Share by Application in 2020 Figure 29. United States Acute Migraine Drugs Sales Growth Rate 2016-2027 (K Unit) Figure 30. United States Acute Migraine Drugs Revenue Growth Rate 2016-2027 (US$ Million) Figure 31. United States Acute Migraine Drugs Market Share in Global Market 2016-2027 Figure 32. United States 5 and 10 Largest Acute Migraine Drugs Players Market Share by Revenue in Acute Migraine Drugs in 2020 Figure 33. United States Acute Migraine Drugs Revenue Share by Type (2016-2021) Figure 34. United States Acute Migraine Drugs Revenue Growth Rate by Type in 2016 & 2020 Figure 35. United States Acute Migraine Drugs Revenue Share by Application (2016-2021) Figure 36. United States Acute Migraine Drugs Revenue Growth Rate by Application in 2016 & 2020 Figure 37. North America Acute Migraine Drugs Sales Growth Rate 2016-2021 (K Unit) Figure 38. North America Acute Migraine Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 39. North America Acute Migraine Drugs Sales Market Share by Country in 2020 Figure 40. North America Acute Migraine Drugs Revenue Market Share by Country in 2020 Figure 41. U.S. Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit) Figure 42. U.S. Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Canada Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit) Figure 44. Canada Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Europe Acute Migraine Drugs Sales Growth Rate 2016-2021 (K Unit) Figure 46. Europe Acute Migraine Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 47. Europe Acute Migraine Drugs Sales Market Share by Country in 2020 Figure 48. Europe Acute Migraine Drugs Revenue Market Share by Country in 2020 Figure 49. Germany Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit) Figure 50. Germany Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 51. France Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit) Figure 52. France Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. U.K. Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit) Figure 54. U.K. Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. Italy Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit) Figure 56. Italy Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Russia Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit) Figure 58. Russia Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Asia Pacific Acute Migraine Drugs Sales Growth Rate 2016-2021 (K Unit) Figure 60. Asia Pacific Acute Migraine Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 61. Asia Pacific Acute Migraine Drugs Sales Market Share by Region in 2020 Figure 62. Asia Pacific Acute Migraine Drugs Revenue Market Share by Region in 2020 Figure 63. China Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit) Figure 64. China Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 65. Japan Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit) Figure 66. Japan Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. South Korea Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit) Figure 68. South Korea Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. India Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit) Figure 70. India Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. Australia Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit) Figure 72. Australia Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Taiwan Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit) Figure 74. Taiwan Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Indonesia Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit) Figure 76. Indonesia Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Thailand Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit) Figure 78. Thailand Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Malaysia Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit) Figure 80. Malaysia Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Philippines Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit) Figure 82. Philippines Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Vietnam Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit) Figure 84. Vietnam Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Latin America Acute Migraine Drugs Sales Growth Rate 2016-2021 (K Unit) Figure 86. Latin America Acute Migraine Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 87. Latin America Acute Migraine Drugs Sales Market Share by Country in 2020 Figure 88. Latin America Acute Migraine Drugs Revenue Market Share by Country in 2020 Figure 89. Mexico Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit) Figure 90. Mexico Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 91. Brazil Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit) Figure 92. Brazil Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Argentina Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit) Figure 94. Argentina Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Middle East and Africa Acute Migraine Drugs Sales Growth Rate 2016-2021 (K Unit) Figure 96. Middle East and Africa Acute Migraine Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 97. Middle East and Africa Acute Migraine Drugs Sales Market Share by Country in 2020 Figure 98. Middle East and Africa Acute Migraine Drugs Revenue Market Share by Country in 2020 Figure 99. Turkey Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit) Figure 100. Turkey Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 101. Saudi Arabia Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit) Figure 102. Saudi Arabia Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. UAE Acute Migraine Drugs Sales Growth Rate (2016-2021) (K Unit) Figure 104. UAE Acute Migraine Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. Acute Migraine Drugs Value Chain Figure 106. Channels of Distribution Figure 107. Distributors Profiles Figure 108. Bottom-up and Top-down Approaches for This Report Figure 109. Data Triangulation Figure 110. Key Executives Interviewed

GSK Teva Pfizer Novartis Sun Pharma Grunenthal Endo Pharmaceuticals Merck J & J